This result is also consistent with the estimation of the incretin effects from the IIGI experiments in this study which showed that the incretin dependent insulin response is the dominant factor in differentiating between the levels of insulin secretion in CS and T2D subjects. The gene discussed is GCG; the disease is type 2 diabetes mellitus.